Detalhe da pesquisa
1.
Molecular epidemiology of vancomycin-resistant enterococci from 6 hospitals in New York State.
Am J Infect Control
; 27(5): 411-7, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10511488
2.
Microbicidal activity of MDI-P against Candida albicans, Staphylococcus aureus, Pseudomonas aeruginosa, and Legionella pneumophila.
Am J Infect Control
; 28(3): 251-7, 2000 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-10840346
3.
Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
Chemotherapy
; 39(5): 302-9, 1993.
Artigo
em Inglês
| MEDLINE | ID: mdl-8396526
4.
Comparison of inhibitory and bactericidal activities and postantibiotic effects of LY333328 and ampicillin used singly and in combination against vancomycin-resistant Enterococcus faecium.
Antimicrob Agents Chemother
; 42(10): 2564-8, 1998 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-9756756
5.
In vitro activity of sparfloxacin and six reference antibiotics against gram-positive bacteria.
Chemotherapy
; 37(4): 275-82, 1991.
Artigo
em Inglês
| MEDLINE | ID: mdl-1665123
6.
Comparative in-vitro susceptibilities of Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas spp. to sparfloxacin (CI-978, AT-4140, PD131501) and reference antimicrobial agents.
J Antimicrob Chemother
; 27(6): 793-9, 1991 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-1657857
7.
Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci.
Chemotherapy
; 47(4): 250-60, 2001.
Artigo
em Inglês
| MEDLINE | ID: mdl-11399861
8.
Antibacterial effect of telithromycin (HMR 3647) and comparative antibiotics against intracellular Legionella pneumophila.
J Antimicrob Chemother
; 46(1): 51-5, 2000 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10882688
9.
Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.
Antimicrob Agents Chemother
; 45(1): 96-104, 2001 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-11120951
10.
Selection for vancomycin resistance in clinical isolates of Staphylococcus haemolyticus.
J Infect Dis
; 161(1): 45-51, 1990 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-2295858
11.
The effect of rifampicin on the in-vitro activity of cefpirome or ceftazidime in combination with aminoglycosides against Pseudomonas aeruginosa.
J Antimicrob Chemother
; 25(4): 575-84, 1990 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-2112539
12.
Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis.
Infect Immun
; 62(7): 2761-72, 1994 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-8005666
13.
Influence of zinc on Pseudomonas aeruginosa susceptibilities to imipenem.
J Clin Microbiol
; 31(9): 2366-70, 1993 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-8408557
14.
Fluconazole and amphotericin B antifungal therapies do not negate the protective effect of endogenous tumor necrosis factor in a murine model of fatal disseminated candidiasis.
J Infect Dis
; 171(2): 406-15, 1995 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-7844378
15.
Effect of pentoxifylline on the course of systemic Candida albicans infection in mice.
J Antimicrob Chemother
; 37(5): 943-54, 1996 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-8737144
16.
Comparative therapy with cefpirome alone and in combination with rifampin and/or gentamicin against a disseminated Pseudomonas aeruginosa infection in leukopenic mice.
J Infect Dis
; 162(5): 1112-7, 1990 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-2121835
17.
In-vitro susceptibilities of gram-positive bacteria to cefpirome, vancomycin, isepamicin and gentamicin, singly and in combination.
J Antimicrob Chemother
; 26(6): 855-7, 1990 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-2081726